银华国证港股通创新药ETF
(159567)公募权益被动型股票型指数型
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-06-30 | 67.37 | 65.44 | 64.46 | 95.56% | 95.69% | 0.00 | 0.00% | 0.00% | 2.69 | 4.11% | 3.99% | 0.22 | 0.33% | 0.32% |
| 2026-03-31 | 78.23 | 76.01 | 74.94 | 95.67% | 95.79% | 0.00 | 0.00% | 0.00% | 2.75 | 3.62% | 3.52% | 0.54 | 0.71% | 0.69% |
| 2025-12-31 | 79.25 | 78.97 | 77.19 | 97.38% | 97.39% | 0.00 | 0.00% | 0.00% | 2.07 | 2.62% | 2.61% | 0.00 | 0.00% | 0.00% |
| 2025-09-30 | 77.76 | 77.01 | 75.15 | 96.61% | 96.63% | 0.00 | 0.00% | 0.00% | 2.06 | 2.67% | 2.65% | 0.56 | 0.72% | 0.72% |
| 2025-06-30 | 29.62 | 27.27 | 26.15 | 87.30% | 88.30% | 0.00 | 0.00% | 0.00% | 3.43 | 12.57% | 11.58% | 0.04 | 0.13% | 0.12% |
| 2025-03-31 | 8.57 | 7.02 | 6.69 | 73.13% | 78.01% | 0.00 | 0.00% | 0.00% | 1.88 | 26.83% | 21.96% | 0.00 | 0.04% | 0.03% |
| 2024-12-31 | 3.84 | 3.78 | 3.67 | 95.56% | 95.63% | 0.00 | 0.00% | 0.00% | 0.17 | 4.44% | 4.37% | 0.00 | 0.00% | 0.00% |
| 2024-09-30 | 2.35 | 2.06 | 1.88 | 77.23% | 80.08% | 0.00 | 0.00% | 0.00% | 0.47 | 22.63% | 19.79% | 0.00 | 0.14% | 0.13% |
| 2024-06-30 | 1.36 | 1.35 | 1.29 | 94.84% | 94.89% | 0.00 | 0.00% | 0.00% | 0.06 | 4.77% | 4.73% | 0.01 | 0.39% | 0.38% |
| 2024-03-31 | 1.48 | 1.38 | 1.33 | 89.07% | 89.82% | 0.00 | 0.00% | 0.00% | 0.15 | 10.79% | 10.05% | 0.00 | 0.14% | 0.13% |